|Day Low/High||58.40 / 59.14|
|52 Wk Low/High||52.83 / 66.41|
After a strong week for the biotech sector, these names have potential catalysts to move shares.
President Trump delivered a highly-anticipated speech on lowering the cost of drugs for Americans on Friday afternoon.
Jim Cramer takes a look at CVS Health, Prestige Brands, LendingTree, Valeant Pharmaceuticals, Nektar Therapeutics, Kirkland Lake and more.
Jim Cramer says Warren Buffett is the greatest investor, and his optimism has suffused trading and has been justified.
Stocks were mixed on Tuesday with investors adopting a cautious stance as the Federal Reserve begins a two-day meeting.
Let's take a look at the charts and indicators to see what may lie ahead for this drug maker.
U.S. stock futures are mixed as the Federal Reserve kicks off a two-day meeting and Apple is scheduled to report quarterly results.
Global stocks bumped higher Tuesday, while oil prices held at three-and-a-half year highs, amid several key market closures and ahead of what could be a crucial quarterly earnings update from Apple after the close of trading.
I think it very possible that there will be a positive reaction tonight, more likely based on what Tim Cook says.
Jim Cramer says foolish traders believe a trade war will trigger a recession, but they're wrong. Fight the crosswinds with a game plan for next week.
The drugmakers and health insurer are preparing to unveil first-quarter numbers.
Procter & Gamble, which is buying the Merck unit, was previously reported to be in talks to acquire Pfizer's consumer healthcare business.
Asia markets traded mostly lower Tuesday, with Hong Kong's benchmark down almost 500 points.
Stocks rise Monday as concerns over prolonged military action in Syria fade and the focus for investors shifts to a heavy upcoming slate of U.S. corporate earnings.
Data and industry conferences will likely be catalysts for shares in the space.
Legendary investor Jim Rogers thinks the market is headed straight for a major sell off. Here's why.
Today, Jim discusses Raytheon, tensions in Syria, bank earnings, Kohl's, Nordstrom and more!
The drugmakers on April 16 released data from their respective studies at the Association for Cancer Research's annual meeting in Chicago.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.